Case Report

Gonadotropin-releasing hormone agonist and depot medroxyprogesterone acetate following uterine artery embolization in the management of uterine arteriovenous malformation

Authors: , , ,

Abstract

A young woman presenting with recurrent episodes of uterine bleeding due to an extensive uterine arteriovenous malformation was treated with two sessions of uterine artery embolization. Further bleeding was managed with a combination of gonadotropin-releasing hormone and depot medroxyprogesterone acetate. The patient remains asymptomatic with a significant decrease in uterine and pelvic vascularity at one year follow-up.

These drugs may decrease the need for repeat embolization.

Keywords: Arteriovenous malformation, uterine artery embolization, gonadotropin-releasing hormone agonist, depot medroxyprogesterone acetate

How to Cite: Krishnaswamy, P. , Subbanna, I. , Sivasambu, G. & Thukral, U. (2014) “Gonadotropin-releasing hormone agonist and depot medroxyprogesterone acetate following uterine artery embolization in the management of uterine arteriovenous malformation”, Proceedings in Obstetrics and Gynecology. 4(1). doi: https://doi.org/10.17077/2154-4751.1203